These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 30528053)
21. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Quon CY; Mai K; Patil G; Stampfli HF Drug Metab Dispos; 1988; 16(3):425-8. PubMed ID: 2900735 [TBL] [Abstract][Full Text] [Related]
22. Neuromuscular interactions between succinylcholine and esmolol in the rat. Chang RY; Chern SC; Chiang YY; Liou MD; Tseng KF; Tsai SK Acta Anaesthesiol Sin; 1994 Sep; 32(3):203-8. PubMed ID: 7921866 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock. Du W; Wang XT; Long Y; Liu DW Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452 [TBL] [Abstract][Full Text] [Related]
24. Effects of Intraoperative Infusion of Esmolol on Systemic and Pulmonary Inflammation in a Porcine Experimental Model of Lung Resection Surgery. Garutti I; Rancan L; Abubakra S; Simón C; Paredes SD; Ortega J; Huerta L; Ramos S; Vara E Anesth Analg; 2019 Jan; 128(1):168-175. PubMed ID: 30234542 [TBL] [Abstract][Full Text] [Related]
25. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia. Wang LL; Han Y; Guo Z; Han SQ; Liu T Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276 [TBL] [Abstract][Full Text] [Related]
26. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model. Jacquet-Lagrèze M; Allaouchiche B; Restagno D; Paquet C; Ayoub JY; Etienne J; Vandenesch F; Dauwalder O; Bonnet JM; Junot S Crit Care; 2015 Jun; 19(1):241. PubMed ID: 26041462 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Gore DC; Wolfe RR Surgery; 2006 May; 139(5):686-94. PubMed ID: 16701103 [TBL] [Abstract][Full Text] [Related]
28. The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. Harwood TN; Butterworth J; Prielipp RC; Royster RL; Hansen K; Plonk G; Dean R J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):555-61. PubMed ID: 10527224 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of intrathecal esmolol on heat-evoked responses in a postoperative pain model. Ono H; Ohtani N; Matoba A; Kido K; Yasui Y; Masaki E Am J Ther; 2015; 22(2):111-6. PubMed ID: 23411610 [TBL] [Abstract][Full Text] [Related]
30. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery. Asouhidou I; Trikoupi A BMC Anesthesiol; 2015 Nov; 15():172. PubMed ID: 26615516 [TBL] [Abstract][Full Text] [Related]
31. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2002 Aug; 124(2):340-51. PubMed ID: 12167795 [TBL] [Abstract][Full Text] [Related]
32. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution. Fujii M; Chambers DJ Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477 [TBL] [Abstract][Full Text] [Related]
33. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806 [TBL] [Abstract][Full Text] [Related]
34. Esmolol inhibits Na+ current in rat ventricular myocytes. Deng CY; Lin SG; Zhang WC; Kuang SJ; Qian WM; Wu SL; Shan ZX; Yang M; Yu XY Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):697-702. PubMed ID: 17235414 [TBL] [Abstract][Full Text] [Related]
35. The effect of the ultrashort beta-blocker esmolol on cardiac function recovery: an experimental study. Pirk J; Kolár F; Ost'ádal B; Sedivý J; Stambergová A; Kellovský P Eur J Cardiothorac Surg; 1999 Feb; 15(2):199-203. PubMed ID: 10219554 [TBL] [Abstract][Full Text] [Related]
37. Intravenous glutamine administration reduces lung and distal organ injury in malnourished rats with sepsis. de Oliveira GP; Silva JD; de Araújo CC; Prota LF; Abreu SC; Madeira C; Morales MM; Takiya CM; Diaz BL; Capelozzi VL; Panizzutti R; Pelosi P; Rocco PR Shock; 2014 Mar; 41(3):222-32. PubMed ID: 24430537 [TBL] [Abstract][Full Text] [Related]
38. Esmolol administration in patients with VV ECMO: why not? Pappalardo F; Zangrillo A; Pieri M; Landoni G; Morelli A; Stefani M; Guarracino F J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):e40. PubMed ID: 23735468 [No Abstract] [Full Text] [Related]
39. Combining Epinephrine and Esmolol Attenuates Excessive Autophagy and Mitophagy in Rat Cardiomyocytes After Cardiac Arrest. Lu J; Shen Y; Liu LJ; Qian HY; Zhu CL J Cardiovasc Pharmacol; 2015 Nov; 66(5):449-56. PubMed ID: 26222992 [TBL] [Abstract][Full Text] [Related]
40. Beta-blocker use in severe sepsis and septic shock: a systematic review. Sanfilippo F; Santonocito C; Morelli A; Foex P Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]